Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to Engage Medical Affairs

Engagement with Medical Affairs is critical at every juncture in the drug development process, with Medical Affairs acting as a key liaison between internal stakeholders, a new generation of physicians, and patient advocates...
Read More

Top Stories

Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Health Literacy Month

Celebrating Health Literacy Month 2024:

October is Health Literacy Month, a reminder of the...
world patient safety day

Celebrating World Patient Safety Day 2024:

On World Patient Safety Day 2024, we focus on the critical...
UX design for scientific writing

Future of Scientific Writing and Journal Articles with UX Design

Take a look at some ideas and examples on how user experience design can be...
ISMPP full report image

17th Virtual Annual Meeting of ISMPP: A Summarized Report

Session summaries from the latest ISMPP conference on trust and equity in science, digital transformation...
Pexels Anna Shvets

How Academic Societies Are Embracing the New Digital World: A Look at the Years Gone by and Ahead

The pandemic has required traditional academic societies to rapidly pivot to digital formats for conferences...
To preprint or not to preprint: A debate at the ISMPP

To Preprint or Not to Preprint: Debate at the 17th Annual ISMPP Meeting

The Covid-19 pandemic has brought with it a deluge of preprints. While timely sharing of...
Digital therapeutics and medical communications

Digital Therapeutics and Medical Communications: Are We Ready?

Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...
EU MedTech Summit 2020

EU MedTech Summit 2020: Highlights and Top 3 Takeaways

How is the MedTech industry gearing up for the EU-MDR? Here are some key takeaways...

Learn more ABOUT our company.